Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

NCT03003962 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

669

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Carcinoma NSCLC

Interventions

DRUG: Durvalumab (MEDI4736)
DRUG: Paclitaxel + carboplatin
DRUG: Gemcitabine + cisplatin
DRUG: Gemcitabine + carboplatin
DRUG: Pemetrexed + cisplatin
DRUG: Pemetrexed + carboplatin

Sponsor

AstraZeneca